Skip to main content

Light Horse Therapeutics

San Diego, United States

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

$62.0M raised
Jan 2025
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Light Horse Therapeutics

How much funding has Light Horse Therapeutics raised?
Light Horse Therapeutics has raised $62.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Who are Light Horse Therapeutics's investors?
Light Horse Therapeutics's investors include AbbVie, Mubadala Capital, Versant Ventures, Bristol-Myers Squibb, Taiho Ventures.
Where is Light Horse Therapeutics headquartered?
Light Horse Therapeutics is headquartered in San Diego, United States.
What does Light Horse Therapeutics do?
Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.
What stage is Light Horse Therapeutics at?
Light Horse Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Light Horse Therapeutics — Funding & Investors." VCBacked, January 9, 2025, https://www.vcbacked.co/company/light-horse-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Light Horse Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/light-horse-therapeutics
Wikipedia (cite web)
{{cite web |title=Light Horse Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/light-horse-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .